General Information of the Compound
| Compound ID |
CP0372552
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl]-3-[2-[2-[2-[2-[3-[4-[4-(2-methoxyphenyl)piperazin-1-yl]butylcarbamoyl]phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C52H72N6O9
|
||||||||||||||||||
| Molecular Weight |
925.181
|
||||||||||||||||||
| Canonical SMILES |
COc1ccccc1N1CCN(CCCCNC(=O)c2cccc(OCCOCCOCCOCCOc3cccc(c3)C(=O)NCCCCN3CCN(CC3)c3ccccc3OC)c2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C52H72N6O9/c1-61-49-19-5-3-17-47(49)57-29-25-55(26-30-57)23-9-7-21-53-51(59)43-13-11-15-45(41-43)66-39-37-64-35-33-63-34-36-65-38-40-67-46-16-12-14-44(42-46)52(60)54-22-8-10-24-56-27-31-58(32-28-56)48-18-4-6-20-50(48)62-2/h3-6,11-20,41-42H,7-10,21-40H2,1-2H3,(H,53,59)(H,54,60)
Show/Hide
|
||||||||||||||||||
| InChIKey |
LEFBFLOSCAEZAG-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01005, D(2) dopamine receptor
Protein ID: PT00943, D(3) dopamine receptor
Protein ID: PT01161, D(4) dopamine receptor